Peking University scriptor Yunlong Cao Named New Coronavirus Research
De XV Decembris MMXXII, naturae annunciavit eius natura X, a album of decem qui fuerunt pars anni major scientificis rebus, et cuius fabulis offerre unicum perspective in aliqua signa scientificis in singularibus in quadam significant scientificis de singularibus anno.
In a year of crises and exciting discoveries, Nature chose ten people from astronomers who have helped us understand the universe's most distant existence, to researchers who have been instrumental in the New Crown and monkeypox epidemics, to surgeons who have broken the limits of organ transplantation, says Rich Monastersky, editor-in-chief of Nature Features.
Yunlong Cao est a biomedical Fines innovation Center (Biopic) ad Peking University. Dr. Cao graduated from Zhejiang University with a Bachelor's degree in Physics and received his PhD from Harvard University's Department of Chemistry and Chemical Biology under Xiaoliang Xie, and is currently a Research Associate at the Biomedical Frontier Innovation Center at Peking University. Yunlong CAO est focusing in progressionem unius-cellula sequencing technologiae, et investigationem habet adiuvisti ad track evolutione novi coronaviruses et praedicere quidam de mutationibus, quae ducunt ad creationem novis mutatam modos.
De XVIII May MMXX, Xiaoliang Xie / Yunlong CAO et al. Published in charta in in cellula competit: "Potentior neutralizing antibodies contra Sars-Cov-II identified per summus throughput unum-cellula sequencing de convalescent aegris 'B cellulis" in investigationis chartam.
Hoc studium refert eventus a novo coronavirus (Sars, Cov-II) neutralizing Antibdy screen, quod usus est summus-throughput una-cell, alligatus Monoclonal ex in (VIII) D above-teng1 in in LX recuperavit COELO-XIX aegris.
Hoc studium demonstrat primum quod summus throughput una-cellula sequencing potest adhiberi directe ad medicamento inventa et habet utilitatem entis celeri et efficax processus, quod promittit ut revolutionis per viam populi screen pro neutralizing antibodiis ad infectiosis virus.
De XVII Iunii MMXXII, Xiaoliang Xie / Yunlong CAO et al. Published in charta inscribitur: Ba.2.12.1, Ba.4 et Ba.5 effugium elicitur ab omicron infectio in Acta naturam.
Hoc studium invenitur quod novum subtypys de omicron mutant strains Ba.2.12.1, Ba.4 et Ba.5 ostendit auctus immune effugium et a significant neutralization de Plasma evadere in recuperavit omicron-inficiuntur aegris.
His Inventiones suadeant quod Ba.1-fundatur omicron vaccine ut non sit idoneam sicut cursus in current immunization context et quod antibodias adductus non providere lata-spectro tutela contra novum mutant iactabantur. Ceterum grex immunitatem per omicron infectio est maxime difficile ad consequi debitum ad 'immunogenic' phaenomenon novum coronaviruses et celeri evolutione immune effugium mutationem sites.
De XXX Octobris MMXXII, Xiaoliang Xie / Yunlong CAO scriptor Team published in Research Paper Competit: imprimit Sars-Cov-II Humus dignitate inducit Converrice RBD evolution in preptrints ConverenthiV.
This study suggests that the advantage of XBB over BQ.1 may be due in part to changes outside the receptor binding domain (RBD) of the spinosin, that XBB also has mutations in parts of the genome encoding the N-terminal structural domain (NTD) of the spinosin, and that XBB is able to escape neutralizing antibodies against the NTD, which may allow it to infect people immune to BQ.1 and related subtypes. Tamen, quod est dignum quod mutationes in NTD regionem sunt occurrentes in BQ.1 ad maxime celeri rate. Hae mutationes valde augendae facultatem variants evadere neutralizing antibodias produci per vaccination et prior infectiones.
Dr. Yunlong Cao dixit quod non potest esse quaedam tutela in XBB si infectam cum BQ.1, sed ulteriorem investigationem est opus providere quod hoc.
In addition ut Yunlong Cao, duo alii fecit album pro outstanding contributions ad global publicam salutem exitibus, Lisa McCorkell et Dimie Ogoina.
Lisa McCorkell est researcher cum Long Covi et sicut conditam membrum de patientes estote investigationis collaborative, quae adiuvit ad suscitavit conscientia et funding ad research in morbo.
Dimie Ogoina est infectious morbus medicus ad Nigri Delta University in Nigeria et operis in monkkox pestis in Nigeria habet provisum clavem notitia in pugna contra monkeicorum epidemiam.
De X Ianuarii MMXXII, The University of Maryland School of Medicine nuntiatum mundi primum felix gene-edited by Porcus Cordis implantare in viventem homo, cum LVII-edited by Pigh TRANSPLAT CORPUS TRANSPLAVE accepit a gene-edited by Pig TRANSPLAT EST AD SECUNDUS PUG PUGNITUS ad animam suam.
Licet hoc pig cor habet tantum extenditur David Bennett vitam per duos menses, quod fuit ingens victoria et historic breakthrough in agro Xenotransplantation. Muhammad Mohiuddin, in medicus qui duxit in quadrigis qui perficitur hoc humanum traducere de genere-edited by Porcus Cordis, quod dubium nomine ad naturam Top X populus anni album.
Plures alii electus pro advancing incredibili scientific res gestae et momenti consilium progreditur, inter Astronomer Jane Kessinger NASA scriptor Goddard Space Center, qui lusit a key munus in Webb spatium Telescope scriptor missio ad adepto in Webb in spatio et operantes in novam et altiorem. Ave Nelson, sicut US Science and Technology Policy agens Director De Officio Science and Technology, adiuvisti ad administrationem Praesidem Biden develop momenti elementa suae scientiae et novum in aperto scientia. Dianae Greenorii Foster, an Abortus Researcher et Demographer ad University of California, San Francisco, provisum key data in expectata impulsum in US Summi Court scriptor arbitrium est evertere legum protectiones ad abortus iura.
Sunt etiam nomina in hoc anno scriptor summo decem album quod pertinet ad progressionem de caeli mutatio et alia global discrimina. Sunt: António, Secretarius-Generalis De United Nations, Saleemul Huq, Director of International Center pro Clima Mutare et Development in Dhaka, Bangladesh et Svitlana Krakovska in Climate Mutare in Climate (IPCC).
Post tempus: Dec 19-2022